Discovery of Nonpeptide, Reversible HER1/HER2 Dual-Targeting Small-Molecule Inhibitors as Near-Infrared Fluorescent Probes for Efficient Tumor Detection, Diagnostic Imaging, and Drug Screening-Reference-Cited by-同舟云学术

Discovery of Nonpeptide, Reversible HER1/HER2 Dual-Targeting Small-Molecule Inhibitors as Near-Infrared Fluorescent Probes for Efficient Tumor Detection, Diagnostic Imaging, and Drug Screening

Published:2018-12-21 Issue:2 Volume:91 Page:1507-1515
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Liu Shengnan,Song Weijie,Gao Xiangqian¹,Su Yanxin,Gao Emily²,Gao Qingzhi^ORCID

Affiliation:

1. Department of Biology, Gudui BioPharma Technology Incorporated, 5 Lanyuan Road, Huayuan Industrial Park, Tianjin 300384, People’s Republic of China

2. UCI School of Biological Sciences, University of California, Irvine, Irvine, California 92697, United States

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.8b04633

Reference29 articles.

1. Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer